# SHR-A1904 in Advanced Colorectal Cancer: an Exploratory Study

> **NCT07700719** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Peking University Cancer Hospital & Institute** · enrollment: 17 (estimated)

## Conditions studied

- Colorectal Cancer Metastatic

## Interventions

- **DRUG:** SHR-A1904

## Key facts

- **NCT ID:** NCT07700719
- **Lead sponsor:** Peking University Cancer Hospital & Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-07-28
- **Primary completion:** 2027-11-28
- **Final completion:** 2028-04-28
- **Target enrollment:** 17 (ESTIMATED)
- **Last updated:** 2026-07-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07700719

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07700719, "SHR-A1904 in Advanced Colorectal Cancer: an Exploratory Study". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07700719. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*